Equities

Cencosud SA

CENCOSUD:SGO

Cencosud SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CLP)1,961.00
  • Today's Change30.60 / 1.59%
  • Shares traded1.55m
  • 1 Year change+23.72%
  • Beta0.8094
Data delayed at least 20 minutes, as of Nov 21 2024 19:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform4
Hold7
Sell1
Strong Sell0

Share price forecast in CLP

The 13 analysts offering 12 month price targets for Cencosud SA have a median target of 2,050.00, with a high estimate of 2,500.00 and a low estimate of 1,600.00. The median estimate represents a 4.54% increase from the last price of 1,961.00.
High27.5%2,500.00
Med4.5%2,050.00
Low-18.4%1,600.00

Dividends in CLP

In 2023, Cencosud SA reported a dividend of 103.00 CLP, which represents a 18.90% decrease from last year. The 4 analysts covering the company expect dividends of 64.55 CLP for the upcoming fiscal year, a decrease of 37.33%.
Div growth (TTM)-18.90%
More ▼

Earnings history & estimates in CLP

On Nov 06, 2024, Cencosud SA reported 3rd quarter 2024 earnings of 26.20 per share.
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate+88.54%
Cencosud SA reported annual 2023 earnings of 77.00 per share on Mar 05, 2024.
Average growth rate+456.65%
More ▼

Revenue history & estimates in CLP

Cencosud S.A. had 3rd quarter 2024 revenues of 3.77bn. This missed the 3.83bn consensus estimate of the 4 analysts following the company. This was 7.64% above the prior year's 3rd quarter results.
Average growth rate+0.36%
Cencosud S.A. had revenues for the full year 2023 of 14.23bn. This was 0.20% above the prior year's results.
Average growth rate+11.04%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.